United Therapeutics Corporation
US ˙ NasdaqGS ˙ US91307C1027

SecurityUTHR / United Therapeutics Corporation
InstitutionFranklin Resources Inc
Latest Disclosed Ownership277,983 shares
Latest Disclosed Value $ 164,838,454
Franklin Resources Inc reports 53.48% increase in ownership of UTHR / United Therapeutics Corporation

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 277,983 shares of United Therapeutics Corporation (US:UTHR) valued at $164,838,359 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 181,120 shares of United Therapeutics Corporation. This represents a change in shares of 53.48% during the quarter. The current value of the position is $152,248,509 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 277,983 96,863 53.48 164,838 86.79 0.0066
2026-02-11 2025-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 181,120 118,454 189.02 88,251 235.93 0.0217
2025-11-13 2025-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 62,666 -79,432 -55.90 26,270 -35.66 0.0066
2025-08-12 2025-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 142,098 -102,014 -41.79 40,832 -45.74 0.0108
2025-05-13 2025-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 244,112 -85,267 -25.89 75,252 -35.25 0.0217
2025-02-12 2024-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 329,379 78,660 31.37 116,218 29.81 0.0323
2024-11-27 2024-09-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 250,719 123,929 97.74 89,532 121.68 0.0251
2024-11-12 2024-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 250,719 123,929 89,532 0.0043
2024-08-14 2024-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 126,790 87,868 225.75 40,389 351.72 0.0124
2024-05-13 2024-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 38,922 -10,929 -21.92 8,941 -18.43 0.0028
2024-02-09 2023-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 49,851 38,915 355.84 10,962 343.77 0.0051
2023-11-13 2023-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 10,936 3,582 48.71 2,470 52.19 0.0013
2023-08-11 2023-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 7,354 -3,578 -32.73 1,623 -33.70 0.0008
2023-05-12 2023-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 10,932 -521 -4.55 2,448 -23.12 0.0012
2023-02-10 2022-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 11,453 695 6.46 3,185 41.39 0.0017
2022-11-14 2022-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 10,758 2,016 23.06 2,252 9.32 0.0012
2022-08-11 2022-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 8,742 3,685 72.87 2,060 126.62 0.0010
2022-05-13 2022-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 5,057 -16,957 -77.03 909 -80.89 0.0004
2022-02-11 2021-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 22,014 2,488 12.74 4,756 31.93 0.0017
2021-11-12 2021-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 19,526 14,853 317.85 3,605 330.19 0.0014
2021-08-13 2021-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 4,673 -6,260 -57.26 838 -54.18 0.0003
2021-05-13 2021-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 10,933 -10,755 -49.59 1,829 -44.44 0.0007
2021-02-10 2020-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 21,688 1,101 5.35 3,292 58.35 0.0014
2020-11-12 2020-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 20,587 20,587 2,079 0.0010
2019-11-14 2019-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 0 -29,566 -100.00 0 -100.00
2019-08-14 2019-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 29,566 6,732 29.48 2,308 -13.88 0.0012
2019-05-15 2019-03-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 22,834 4,931 27.54 2,680 37.51 0.0014
2019-05-14 2019-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 22,834 4,931 2,680
2019-02-12 2018-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 17,903 1,391 8.42 1,949 -7.67 0.0012
2018-11-13 2018-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 16,512 2,293 16.13 2,111 31.12 0.0011
2018-08-14 2018-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 14,219 4,051 39.84 1,610 40.98 0.0008
2018-05-10 2018-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 10,168 1,280 14.40 1,142 -13.22 0.0006
2018-02-14 2017-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 8,888 4,389 97.56 1,316 149.24 0.0006
2017-11-13 2017-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 4,499 1,890 72.44 528 55.75 0.0003
2017-08-10 2017-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 2,609 -244,991 -98.95 339 -98.54 0.0002
2014-05-13 2014-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 247,600 19,400 8.50 23,282 -9.78 0.0110
2014-02-12 2013-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 228,200 9,000 4.11 25,805 49.30 0.0126
2013-11-14 2013-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 219,200 23,500 12.01 17,284 34.18 0.0092
2013-08-09 2013-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 195,700 195,700 12,881 0.0074
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.